'Most of the city is evacuating': Gridlock on Alberta highway after evacuation order in Fort McMurray
Four Fort McMurray neighbourhoods were ordered to evacuate on Tuesday as a wildfire gets closer to the city.
Scientists in the U.K. are developing a “potentially significant” treatment for COVID-19 that could be administered to patients in the form of a nasal spray, thanks to the tiny antibodies produced by a llama.
According to research from the Rosalind Franklin Institute, which was recently published in the journal Nature Communications, the treatment has the potential to prevent and treat COVID-19.
“While vaccines have proven extraordinarily successful, not everyone responds to vaccination and immunity can wane in individuals at different times,” James Naismith, director of the Rosalind Franklin Institute, who helped lead the research, said in a statement.
“Having medications that can treat the virus is still going to be very important, particularly as not all of the world is being vaccinated at the same speed and there remains a risk of new variants capable of bypassing vaccine immunity emerging.”
To develop the treatment, researchers injected a llama named Fifi with a tiny, non-infectious piece of purified spike protein from the SARS-CoV-2 virus – the virus that causes COVID-19.
The scientists chose a llama specifically because of the species’ unique ability to produce tiny single-domain antibodies – or nanobodies – in response to an infection. Other camelids including alpacas and camels, and even sharks, can produce these nanobodies too.
Due to their small size, these nanobodies are able to bind more tightly to the SARS-CoV-2 virus than larger antibodies produced by humans. Once the nanobodies have latched on to the invading virus, the body’s immune system flags it for destruction.
Steven Kerfoot, an associate professor of microbiology and immunology at Western University in London, Ont., who was not involved in the research, said the big advantage of these smaller nanobodies is their ability to squeeze into tight spaces on a virus protein. He also said they’re much easier to produce in a lab than human antibodies.
“It’s a lot easier to put together, a lot less complicated, and it's smaller, and can really sort of get into that binding spot quite well,” Kerfoot told CTVNews.ca during a telephone interview on Thursday. “So there are some real advantages for this particular approach.”
Ray Owens, head of protein production at the Rosalind Franklin Institute and lead author of the research, agreed the nanobodies have a number of advantages over human antibodies.
“Nanobodies have a number of advantages over human antibodies,” Ray Owens, head of protein production at the Rosalind Franklin Institute and lead author of the research, said in a statement.
“They are cheaper to produce and can be delivered directly to the airways through a nebuliser or nasal spray, so can be self-administered at home rather than needing an injection.”
Throughout the pandemic, human antibodies have been used to treat serious cases of COVID-19, but they typically need to be administered by intravenous infusion in the hospital. The nanobodies, on the other hand, could be delivered in the form of a simple nasal spray.
“This could have benefits in terms of ease of use by patients but it also gets the treatment directly to the site of infection in the respiratory tract,” Owens added.
Returning to Fifi the llama, after the animal was injected with a small piece of the virus’ spike protein, its immune system was triggered to fight off the virus protein by generating nanobodies against it. Following this, the researchers took a sample of Fifi’s blood and purified four nanobodies from it that were capable of binding to the SARS-CoV-2 virus.
These nanobodies were then engineered in a lab into chains of three to increase their ability to bind to the virus.
Llamas have the unique ability to produce tiny single-domain antibodies – or nanobodies – in response to an infection. (Jo Kelly / Rosalind Franklin Institute)
The team found that three of the chains were able to neutralize the original variants of the SARS-CoV-2 virus and the Alpha variant, while a fourth chain was effective in neutralizing the Beta variant.
When one of the chains of nanobodies was tested in hamsters infected with COVID-19, the rodents showed a “marked reduction” in disease, lost far less weight than those that weren’t treated, and a had a lower viral load in their lungs and airways after seven days compared to those left untreated.
While the treatment has only been tested in animals, Public Health England said it was among the “most effective” SARS-CoV-2 neutralizing treatments they have ever tested.
“Although this research is still at an early stage, it opens up significant possibilities for the use of effective nanobody treatments for COVID-19,” Miles Carroll, Deputy Director of the National Infection Service, Public Health England (PHE), said.
Kerfoot said the idea of using antibodies from llamas and other animals in the camelid family is not new and has been in development for some time, but he’s not aware of its use in human treatment yet. He said the pandemic might provide the right impetus to further the research along, as it was for the mRNA technology now used in COVID-19 vaccines.
“If this becomes an approach that we can use to try and lessen the severity of respiratory viruses, there could be a lot of benefit to that. It's just not something that has made the leap to human treatment yet and this may be the push that sort of pushes it over that edge,” he said.
As for next steps, the team of researchers, which included scientists from the University of Liverpool, University of Oxford and PHE, are hoping to obtain funding in order to conduct clinical studies in humans. They also hope their nanobody technology might one day be used as a “platform technology” to fight off other diseases.
“When a new virus emerges in the future, the generic technology we have developed could respond to that, which would be important in terms of producing new treatments as quickly as possible,” Owens said.
Kerfoot agreed that there is a lot of potential to use this approach as a standard treatment for other airway diseases.
“There’s nothing special about SARS-CoV-2 that this approach wouldn't work for many of the other airway viruses,” he said. “I think there's certainly promise and the next step will have to be moving into human trials.”
Four Fort McMurray neighbourhoods were ordered to evacuate on Tuesday as a wildfire gets closer to the city.
Saskatchewan RCMP have revealed that a historic sexual assault investigation has led to the discovery of alleged crimes against children dating back to 2005.
Less than a week after two public sculptures featuring a livestream between Dublin, Ireland, and New York City debuted, 'inappropriate behaviour' in real-time interactions between people in the two cities has prompted a temporary shutdown.
After a final frame that saw the visiting Vancouver Canucks claw their way back and tie the game late, a slap shot from the point by Oilers defenceman Evan Bouchard with 38 seconds left (until what seemed like certain overtime) iced the 3-2 victory for Edmonton to knot the series.
Kansas City Chiefs kicker Harrison Butker railed against Pride month, working women, President Biden's leadership during the COVID-19 pandemic and abortion during a commencement address at Benedictine College last weekend.
King Charles III has unveiled the first portrait of the monarch completed since he assumed the throne, a vivid image that depicts him in the bright red uniform of the Welsh Guards against a background of similar hues.
The annual list of Canada's top restaurants in the country was just released and here are the places that made the 2024 cut.
The province has released more information on its plan to break up Alberta Health Services and replace it with four sector-based health agencies.
The Biden administration has told key lawmakers it is sending a new package of more than US$1 billion in arms and ammunition to Israel, two congressional aides said Tuesday.
A team is ready to help an entangled North Atlantic right whale in the Gulf of St. Lawrence.
A $200 reward is being offered by a North Vancouver family for the safe return of their beloved chicken, Snowflake.
Two daughters and a mother were reunited online 40 years later thanks to a DNA kit and a Zoom connection despite living on three separate continents and speaking different languages.
Mother's Day can be a difficult occasion for those who have lost or are estranged from their mom.
YES Theatre Young Company opened its acclaimed kids’ show, One Small Step, at Sudbury Theatre Centre on Saturday.
An Ottawa pizzeria is being recognized as one of the top 20 deep-dish pizzas in the world.
A family of fifth generation farmers from Ituna, Sask. are trying to find answers after discovering several strange objects lying on their land.
A Listowel, Ont. man, drafted by the Hamilton Tigercats last week, is also getting looks from the NFL, despite only playing 27 games of football in his life.
The threat of zebra mussels has prompted the federal government to temporarily ban watercraft from a Manitoba lake popular with tourists.